Flyer

Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 18
  • Journal CiteScore: 4.35
  • Journal Impact Factor: 3.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Perspective - (2023) Volume 14, Issue 2

The gut-brain axis: Implications for neurological disorders

Eugen Trinka*
 
Department of Neurology, Christian Doppler University Hospital, Salzburg, Austria
 
*Correspondence: Eugen Trinka, Department of Neurology, Christian Doppler University Hospital, Salzburg, Austria, Email:

Received: 15-Mar-2023, Manuscript No. ipjnn-23-13656; Editor assigned: 17-Mar-2023, Pre QC No. P-13656; Reviewed: 31-Mar-2023, QC No. Q-13656; Revised: 06-Apr-2023, Manuscript No. R-13656; Published: 14-Apr-2023

Introduction

The human body is a complex system that comprises various organs, tissues, and cells, each performing a unique function. However, these different parts of the body are interconnected and communicate with each other to maintain the body's homeostasis. One such example of communication is the gut-brain axis, which refers to the bidirectional communication pathway between the gut and the brain. The gut-brain axis involves the nervous system, immune system, and endocrine system and plays a crucial role in regulating various bodily functions, including digestion, metabolism, and mood. In recent years, research has shown that the gut-brain axis also plays a crucial role in neurological disorders such as Parkinson's disease, Alzheimer's disease, multiple sclerosis, and autism spectrum disorder. This has led to an increased interest in understanding the gut-brain axis and its implications for neurological disorders. In this note, we will explore the gut-brain axis in more detail and discuss its potential implications for neurological disorders [1].

Description

The gut-brain axis is a complex communication pathway between the gut and the brain. This pathway involves various components, including the enteric nervous system (ENS), the vagus nerve, and the hypothalamic-pituitaryadrenal (HPA) axis. The ENS is a network of neurons and glial cells that control the gastrointestinal tract's motility and secretory functions. The vagus nerve is a major nerve that connects the gut and the brain and is involved in various bodily functions, including digestion and heart rate. The HPA axis is a complex system that regulates the body's response to stress [2].

Recent research has shown that the gut microbiome, which comprises trillions of microorganisms living in the gastrointestinal tract, plays a crucial role in the gut-brain axis. The gut microbiome can influence the immune system, metabolism, and brain function. Alterations in the gut microbiome composition have been linked to neurological disorders such as Parkinson's disease, Alzheimer's disease, multiple sclerosis, and autism spectrum disorder. These alterations can lead to inflammation, oxidative stress, and neurodegeneration in the brain [3].

Furthermore, the gut microbiome can also affect the efficacy of drugs used to treat neurological disorders. For example, some studies have suggested that the efficacy of antidepressants can be influenced by the gut microbiome. This highlights the importance of understanding the gutbrain axis and its implications for neurological disorders [4].

As a result, various interventions, including probiotics, prebiotics, and fecal microbiota transplantation, have been proposed as potential treatments for neurological disorders. However, more research is needed to fully understand the role of the gut microbiome in neurological disorders and to develop effective treatments based on this knowledge. Overall, the gut-brain axis is a fascinating area of research with significant potential implications for neurological disorders' diagnosis and treatment [5].

Conclusion

The gut-brain axis plays a crucial role in regulating various bodily functions and has significant implications for neurological disorders. Recent research has shown that the gut microbiome, which is a key component of the gut-brain axis, can influence brain function and be linked to neurological disorders such as Parkinson's disease, Alzheimer's disease, multiple sclerosis, and autism spectrum disorder. Understanding the gut-brain axis and the gut microbiome's role in neurological disorders can lead to the development of new therapeutic strategies, including interventions such as probiotics, prebiotics, and fecal microbiota transplantation. However, more research is needed to fully understand the gut-brain axis's complexities and the gut microbiome's role in neurological disorders. With further research, we can hope to develop more effective treatments for these challenging and debilitating disorders.

References

  1. Höftberger R, Lassmann H, Berger T, et al. Pathogenic autoantibodies in multiple sclerosis—from a simple idea to a complex concept. Nat Rev Neurol. 2022:1-8.
  2. Google Scholar, Crossref, Indexed at

  3. Baker D, Marta M, Pryce G, et al. Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis. EBioMedicine. 2017; 16:41-50.
  4. Google Scholar, Crossref, Indexed at

  5. Yang JH, Rempe T, Whitmire N, et al. Therapeutic advances in multiple sclerosis. Front Neurol. 2022:1111.
  6. Google Scholar, Crossref, Indexed at

  7. Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain‐Barré syndrome. Cochrane Database Syst Rev. 2017(2).
  8. Google Scholar, Crossref, Indexed at

  9. Cortese I, Chaudhry V, So YT, et al. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurol. 2011; 76(3):294-300.
  10. Google Scholar, Crossref, Indexed at